Abstract
Nicotine addiction is a complex behavioural alteration, in which many neuronal pathways and neurotransmitters are involved. For a long time, dopamine has been considered one of the most important neurotransmitters in mediating the rewarding effects of nicotine. In addition, a great amount of research suggests that the endogenous cannabinoid and opioid systems play an overall modulatory effect on the reward circuitry and participate in the addictive properties of most of the prototypical drugs of abuse. This review focuses on recent behavioural and biochemical data involving these systems in the different processes that contribute to tobacco addiction. A possible role for the endogenous cannabinoid and opioid systems in the rewarding properties of nicotine as well as in the development of nicotine physical dependence and relapse to nicotine-seeking behaviour will be examined. According to preclinical studies, clinical trials suggest that the manipulation of these systems with cannabinoid or opioid antagonists could be a potential therapeutical strategy for treating nicotine addiction.
Keywords: Nicotine, addiction, cannabinoid, opioid, reward, withdrawal syndrome, relapse, self-administration
Current Drug Targets
Title: Endogenous Cannabinoid and Opioid Systems and their Role in Nicotine Addiction
Volume: 11 Issue: 4
Author(s): Rafael Maldonado and Fernando Berrendero
Affiliation:
Keywords: Nicotine, addiction, cannabinoid, opioid, reward, withdrawal syndrome, relapse, self-administration
Abstract: Nicotine addiction is a complex behavioural alteration, in which many neuronal pathways and neurotransmitters are involved. For a long time, dopamine has been considered one of the most important neurotransmitters in mediating the rewarding effects of nicotine. In addition, a great amount of research suggests that the endogenous cannabinoid and opioid systems play an overall modulatory effect on the reward circuitry and participate in the addictive properties of most of the prototypical drugs of abuse. This review focuses on recent behavioural and biochemical data involving these systems in the different processes that contribute to tobacco addiction. A possible role for the endogenous cannabinoid and opioid systems in the rewarding properties of nicotine as well as in the development of nicotine physical dependence and relapse to nicotine-seeking behaviour will be examined. According to preclinical studies, clinical trials suggest that the manipulation of these systems with cannabinoid or opioid antagonists could be a potential therapeutical strategy for treating nicotine addiction.
Export Options
About this article
Cite this article as:
Maldonado Rafael and Berrendero Fernando, Endogenous Cannabinoid and Opioid Systems and their Role in Nicotine Addiction, Current Drug Targets 2010; 11 (4) . https://dx.doi.org/10.2174/138945010790980358
DOI https://dx.doi.org/10.2174/138945010790980358 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The α7 Nicotinic Acetylcholine Receptor Complex: One, Two or Multiple Drug Targets?
Current Drug Targets TRPC Channels and their Implications for Neurological Diseases
CNS & Neurological Disorders - Drug Targets Autism - A Comprehensive Array of Prominent Signs and Symptoms
Current Pharmaceutical Design New Agents and Approaches to Treatment in Niemann-Pick Type C Disease
Current Pharmaceutical Biotechnology Evidence for an Immune Role on Cognition in Schizophrenia: A Systematic Review
Current Neuropharmacology Disorders of Sex Development: A Review
Current Women`s Health Reviews The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Alpha-7 Nicotinic Receptors in Nervous System Disorders: From Function to Therapeutic Perspectives
Central Nervous System Agents in Medicinal Chemistry An Approach to Psychiatric Illness in Rheumatology Clinics
Current Rheumatology Reviews Calcium-engaged Mechanisms of Nongenomic Action of Neurosteroids
Current Neuropharmacology Pharmacological Prevention and Treatment in Clinical At-Risk States for Psychosis
Current Pharmaceutical Design The Yin and Yang of the Ghrelin Gene Products
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Methadone Maintenance Treatment and Cognitive Function: A Systematic Review
Current Drug Abuse Reviews Glutamate and Psychosis Risk
Current Pharmaceutical Design Psychiatric Disorders and TRP Channels: Focus on Psychotropic Drugs
Current Neuropharmacology Targeting the NMDA Receptor for Fear-Related Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Animal Models Used for the Evaluation of Antiretroviral Therapies
Current HIV Research Event-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer’s Disease
Current Alzheimer Research Use of Caffeine and Nicotine in People with Schizophrenia
Current Drug Abuse Reviews Effects of Psychoactive Substances in Schizophrenia – Findings of Structural and Functional Neuroimaging
Current Topics in Medicinal Chemistry